New injection aims to tame liver Scarring—First human trial underway
Disease control
Recruiting now
This early-stage trial is testing a new drug called PHIN-214 (a modified version of terlipressin) in 74 adults with mild-to-moderate liver cirrhosis. The study has two parts: a single dose and then daily injections for 28 days. The main goals are to check safety, find the best do…
Phase: PHASE1 • Sponsor: PharmaIN • Aim: Disease control
Last updated Jun 26, 2026 13:41 UTC